Potential of an Eco-Sustainable Probiotic-Cleaning Formulation in Reducing Infectivity of Enveloped Viruses

Viruses. 2021 Nov 4;13(11):2227. doi: 10.3390/v13112227.

Abstract

The COVID-19 pandemic has deeply influenced sanitization procedures, and high-level disinfection has been massively used to prevent SARS-CoV-2 spread, with potential negative impact on the environment and on the threat of antimicrobial resistance (AMR). Aiming to overcome these concerns, yet preserving the effectiveness of sanitization against enveloped viruses, we assessed the antiviral properties of the Probiotic Cleaning Hygiene System (PCHS), an eco-sustainable probiotic-based detergent previously proven to stably abate pathogen contamination and AMR. PCHS (diluted 1:10, 1:50 and 1:100) was tested in comparison to common disinfectants (70% ethanol and 0.5% sodium hypochlorite), in suspension and carrier tests, according with the European UNI EN 14476:2019 and UNI EN 16777:2019 standards. Human alpha- and beta-coronaviruses hCoV-229E and SARS-CoV-2, human herpesvirus type 1, human and animal influenza viruses, and vaccinia virus were included in the study. The results showed that PCHS was able to inactivate 99.99% of all tested viruses within 1-2 h of contact, both in suspension and on surface. Notably, while control disinfectants became inactive within 2 h after application, the PCHS antiviral action persisted up to 24 h post-application, suggesting that its use may effectively allow a continuous prevention of virus spread via contaminated environment, without worsening environmental pollution and AMR concern.

Keywords: SARS-CoV-2 inactivation; eco-friendly disinfection; enveloped virus decontamination; infection control; prevention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • COVID-19 / prevention & control
  • COVID-19 / virology
  • Coronavirus 229E, Human / drug effects
  • Disinfectants / pharmacology
  • Disinfection / methods*
  • Environmental Microbiology
  • Herpesvirus 1, Human / drug effects
  • Humans
  • Orthomyxoviridae / drug effects
  • Probiotics / pharmacology*
  • SARS-CoV-2 / drug effects
  • Sanitation / methods*
  • Vaccinia virus / drug effects
  • Virus Diseases / prevention & control*
  • Virus Diseases / virology
  • Viruses / drug effects*

Substances

  • Antiviral Agents
  • Disinfectants